• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»nutraceuticals

How PureHealth Research LLC’s VenEase highlights gaps between compression therapy and clinical intervention

By Pallavi Madhiraju on February 14, 2026   Pharma & Biotech  

How PureHealth Research LLC’s VenEase highlights gaps between compression therapy and clinical intervention

Explore why vein health supplements like VenEase are gaining traction, what they change in circulation care, and the risks regulators and clinicians are watching.

Anathapindika Health expands retail footprint, testing detox-first nutraceutical demand in specialty stores

By Soujanya Ravi on February 6, 2026   Features & Analysis  

Anathapindika Health expands retail footprint, testing detox-first nutraceutical demand in specialty stores

Discover what Anathapindika Health’s AlchePharma retail expansion signals for detox-focused nutraceuticals and the evolving wellness retail landscape.

Why Brightseed’s glycemic control data could reshape how GLP-1 companion products are evaluated

By Pallavi Madhiraju on February 5, 2026   Pharma & Biotech  

Why Brightseed’s glycemic control data could reshape how GLP-1 companion products are evaluated

Peer-reviewed data puts Brightseed’s BioMetaControl under the clinical microscope. Find out what this trial means for GLP-1 companions and metabolic care.

What Purity Products UROX formula reveals about the future of urological wellness

By Pallavi Madhiraju on December 31, 2025   Pharma & Biotech  

What Purity Products UROX formula reveals about the future of urological wellness

A representative image depicting natural supplement capsules, reinforcing the rise of clinically formulated nutraceuticals like MyBladder® in urological wellness.

Recent Posts

  • AACR 2026: SAGA Diagnostics pushes Pathlight MRD deeper into metastatic breast and ovarian cancer
  • Agenus AACR 2026 data show immune reprogramming signal in PD-1 refractory gastroesophageal cancer
  • AACR 2026: Can Zai Lab’s zocilurtatug pelitecan change the treatment picture for small cell lung cancer brain metastases?
  • How JANX014 expands Janux Therapeutics’ tumor-activated platform strategy in prostate cancer immunotherapy
  • What Medicus Pharma Ltd.’s SkinJect application signals for Hedgehog pathway-driven cancers
  • Why Bioxodes’ adaptive trial strategy could accelerate approval timelines in stroke therapeutics
  • What Kura Oncology’s latest data reveals about resistance biology in kidney cancer
  • Can Fate Therapeutics, Inc. solve the conditioning chemotherapy problem in CAR T?
  • Could Ampligen become a late-stage pancreatic cancer breakthrough after AIM ImmunoTech’s latest clinical push?
  • What the new J-code means for Glaukos’ Epioxa launch and the future of keratoconus reimbursement
  • Molgramostim review pushed to November: what Savara’s FDA delay means for autoimmune PAP
  • What SurGenTec’s TiLink navigation clearance means for surgeons using minimally invasive SI joint fusion systems
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes